AMANDA GARNER: Open Payments
NPI 1851812531 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,761 in 72 payments from 33 companies in 2025. Trend: 2023 $0 · 2024 $1,027 · 2025 $1,761
Food & beverage: $1,676Education: $85
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $314 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $145 |
| Merck Sharp & Dohme LLC | 4 | $104 |
| GENZYME CORPORATION | 3 | $99 |
| PFIZER INC. | 4 | $91 |
| Genentech USA, Inc. | 4 | $82 |
| GlaxoSmithKline, LLC. | 3 | $76 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| ABBVIE INC. | 3 | $61 |
| Exelixis Inc. | 2 | $56 |
Products named: LYNPARZA, AYVAKIT, KEYTRUDA, FRUZAQLA, OJJAARA, IBRANCE, ENHERTU, CABOMETYX.
Industry payments across GA — which companies pay providers there.
